147 related articles for article (PubMed ID: 23118500)
1. Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA.
Urano T; Suzuki Y
J Biomed Biotechnol; 2012; 2012():208108. PubMed ID: 23118500
[TBL] [Abstract][Full Text] [Related]
2. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
3. Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells.
Suzuki Y; Mogami H; Ihara H; Urano T
Blood; 2009 Jan; 113(2):470-8. PubMed ID: 18922856
[TBL] [Abstract][Full Text] [Related]
4. Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells.
Suzuki Y; Yasui H; Brzoska T; Mogami H; Urano T
Blood; 2011 Sep; 118(11):3182-5. PubMed ID: 21791417
[TBL] [Abstract][Full Text] [Related]
5. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: novel mechanism of the expression and amplification of cell surface-associated fibrinolytic activity demonstrated by real-time imaging analysis.
Suzuki Y; Urano T
J Pharmacol Sci; 2011; 116(1):19-24. PubMed ID: 21498960
[TBL] [Abstract][Full Text] [Related]
6. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ
Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890
[TBL] [Abstract][Full Text] [Related]
7. Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cells.
Suzuki Y; Sano H; Tomczyk M; Brzoska T; Urano T
FEBS Open Bio; 2016 May; 6(5):469-76. PubMed ID: 27419052
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the actin cytoskeleton with microtubules regulates secretory organelle movement near the plasma membrane in human endothelial cells.
Manneville JB; Etienne-Manneville S; Skehel P; Carter T; Ogden D; Ferenczi M
J Cell Sci; 2003 Oct; 116(Pt 19):3927-38. PubMed ID: 12928328
[TBL] [Abstract][Full Text] [Related]
9. The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.
Longstaff C; Thelwell C; Williams SC; Silva MM; Szabó L; Kolev K
Blood; 2011 Jan; 117(2):661-8. PubMed ID: 20966169
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
[TBL] [Abstract][Full Text] [Related]
11. Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site-dependent plasminogen accumulation in microthrombi.
Brzoska T; Tanaka-Murakami A; Suzuki Y; Sano H; Kanayama N; Urano T
PLoS One; 2015; 10(3):e0122196. PubMed ID: 25806939
[TBL] [Abstract][Full Text] [Related]
12. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
13. Regulation of plasminogen activation on cell surfaces and fibrin.
Urano T; Castellino FJ; Suzuki Y
J Thromb Haemost; 2018 May; 16(8):1487-97. PubMed ID: 29779246
[TBL] [Abstract][Full Text] [Related]
14. Herpesviruses enhance fibrin clot lysis.
Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin.
Sorrell AM; Shand JH; Tonner E; Gamberoni M; Accorsi PA; Beattie J; Allan GJ; Flint DJ
J Biol Chem; 2006 Apr; 281(16):10883-9. PubMed ID: 16505491
[TBL] [Abstract][Full Text] [Related]
16. Secretory dynamics of tPA and its modulation by PAI-1 in vascular system.
Suzuki Y; Urano T
Rinsho Ketsueki; 2009 May; 50(5):399-403. PubMed ID: 19483400
[No Abstract] [Full Text] [Related]
17. Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells.
Higazi AA; Ganz T; Kariko K; Cines DB
J Biol Chem; 1996 Jul; 271(30):17650-5. PubMed ID: 8663495
[TBL] [Abstract][Full Text] [Related]
18. Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.
Berg DT; Burck PJ; Berg DH; Grinnell BW
Blood; 1993 Mar; 81(5):1312-22. PubMed ID: 8382971
[TBL] [Abstract][Full Text] [Related]
19. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
Novokhatny V; Medved L; Lijnen HR; Ingham K
J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
[TBL] [Abstract][Full Text] [Related]
20. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.
Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
